LP18783-8
Busulfan
Active
Description
An alkylating agent having a selective immunosuppressive effect on bone marrow. It has been used in the palliative treatment of chronic myeloid leukemia, but although symptomatic relief is provided, no permanent remission is brought about. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), busulfan is listed as a known carcinogen. Source: National Library of Medicine, MeSH 2006
Basic Part Properties
- Part Display Name
- Busulfan
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2000-05-04
- Construct for LOINC Short Name
- Busulfan
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP18783-8 - ConceptMap translate
- https:
//fhir.loinc.org/ConceptMap/$translate?system=http: //loinc.org&code=LP18783-8
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| zh-CN | Chinese (China) | 白消安 Synonyms: C6H14O6S2; |
| fr-CA | French (Canada) | Busulfan |
| et-EE | Estonian (Estonia) | Busulfaan |
| es-ES | Spanish (Spain) | Busulfan |
| it-IT | Italian (Italy) | Busulfan |
| tr-TR | Turkish (Turkey) | Busülfan |
| ru-RU | Russian (Russian Federation) | Бусульфан |
| nl-NL | Dutch (Netherlands) | busulfan |
| fr-BE | French (Belgium) | Busulfan |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright